ValiRx

ValiRx is a UK-listed biopharmaceutical company focused on the development of oncology therapeutics and companion diagnostics.

The company selects and incubates novel drug candidates, including peptide-based compounds targeting prostate cancer, endometriosis, and other solid tumours, progressing them from preclinical evaluation towards clinical development and partnering.

Through its subsidiary Inaphaea BioLabs, ValiRx also offers translational drug discovery services, including cell-based assays and patient-derived cell models, to academic and industry researchers.